HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma

References

• Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: globocan 2000. Int J Cancer. 2001;94(2):153–156. doi:10.1002/ijc.1440
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Muhammad H, Tehreem A, Ting PS, et al. Hepatocellular carcinoma and the role of liver transplantation: a review. J Clin Transl Hepatol. 2019;9(5):738–748.
   Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–390. doi:10.1056/NEJMoa0708857
   PubMed Web of Science ®Google Scholar
• Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised Phase 3 non-inferiority trial. Lancet. 2018;391(10126):1163–1173. doi:10.1016/S0140-6736(18)30207-1
   PubMed Web of Science ®Google Scholar
• Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389(10064):56–66. doi:10.1016/S0140-6736(16)32453-9
   PubMed Web of Science ®Google Scholar
• Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379(1):54–63. doi:10.1056/NEJMoa1717002
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Yim SH, Chung YJ. An overview of biomarkers and molecular signatures in HCC. Cancers. 2010;2(2):809–823. doi:10.3390/cancers2020809
   PubMedGoogle Scholar
• Azad AA, Zoubeidi A, Gleave ME, Chi KN. Targeting heat shock proteins in metastatic castration-resistant prostate cancer. Nat Rev Urol. 2015;12(1):26–36. doi:10.1038/nrurol.2014.320
   PubMed Web of Science ®Google Scholar
• Ischia J, So AI. The role of heat shock proteins in bladder cancer. Nat Rev Urol. 2013;10(7):386–395. doi:10.1038/nrurol.2013.108
   PubMed Web of Science ®Google Scholar
• Zhang L, Fok JH, Davies FE. Heat shock proteins in multiple myeloma. Oncotarget. 2014;5(5):1132–1148. doi:10.18632/oncotarget.1584
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006;31(3):164–172. doi:10.1016/j.tibs.2006.01.006
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhuang L, Szatmary P, et al. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumor tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma. Int J Med Sci. 2015;12(3):256–263. doi:10.7150/ijms.10735
   PubMed Web of Science ®Google Scholar
• Sharma A, Upadhyay AK, Bhat MK. Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells. Cancer Biol Ther. 2009;8(22):2106–2113. doi:10.4161/cbt.8.22.9687
   PubMed Web of Science ®Google Scholar
• Yang N, Li S, Li G, et al. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma. Oncotarget. 2017;10(2):3683–3695. doi:10.18632/oncotarget.12465
   Google Scholar
• Chen R, Dai RY, Duan CY, et al. Unfolded protein response suppresses cisplatin-induced apoptosis via autophagy regulation in human hepatocellular carcinoma cells. Folia Biol. 2011;57(3):87–95.
   PubMed Web of Science ®Google Scholar
• Lang SA, Moser C, Fichnter-Feigl S, et al. Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice. Hepatology. 2009;49(2):523–532. doi:10.1002/hep.22685
   PubMed Web of Science ®Google Scholar
• Liu CC, Jan YJ, Ko BS, et al. 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma. BMC Cancer. 2014;14:425. doi:10.1186/1471-2407-14-425
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang Y, Guo K, et al. Heat shock proteins in hepatocellular carcinoma: molecular mechanism and therapeutic potential. Int J Cancer. 2016;138(8):1824–1834. doi:10.1002/ijc.29723
   PubMed Web of Science ®Google Scholar
• Heikkila JJ. The expression and function of hsp30-like small heat shock protein genes in amphibians, birds, fish, and reptiles. Comp Biochem Physiol a Mol Integr Physiol. 2017;203:179–192. doi:10.1016/j.cbpa.2016.09.011
   PubMed Web of Science ®Google Scholar
• Franck E, Madsen O, Van Rheede T, Ricard G, Huynen MA, De Jong WW. Evolutionary diversity of vertebrate small heat shock proteins. J Mol Evol. 2004;59(6):792–805. doi:10.1007/s00239-004-0013-z
   PubMed Web of Science ®Google Scholar
• Kirbach BB, Golenhofen N. Differential expression and induction of small heat shock proteins in rat brain and cultured hippocampal neurons. J Neurosci Res. 2011;89(2):162–175. doi:10.1002/jnr.22536
   PubMed Web of Science ®Google Scholar
• Peferoen LA, Gerritsen WH, Breur M, et al. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter. Acta Neuropathol Commun. 2015;3:87. doi:10.1186/s40478-015-0267-2
   PubMed Web of Science ®Google Scholar
• Zhu Z, Reiser G. The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases. Neurochem Int. 2018;115:69–79. doi:10.1016/j.neuint.2018.02.006
   PubMed Web of Science ®Google Scholar
• Cheng W, Li M, Jiang Y, et al. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. J Neurosurg. 2016;125(1):7–16. doi:10.3171/2015.5.JNS142437
   PubMed Web of Science ®Google Scholar
• Zoltan L, Farkas R, Schally AV, et al. Possible predictive markers of response to therapy in esophageal squamous cell cancer. Pathol Oncol Res. 2019;25(1):279–288. doi:10.1007/s12253-017-0342-z
   PubMed Web of Science ®Google Scholar
• Turi Z, Hocsak E, Racz B, et al. Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancy. J Cancer. 2015;6(5):470–476. doi:10.7150/jca.11494
   PubMed Web of Science ®Google Scholar
• Pozsgai E, Gomori E, Szigeti A, et al. Correlation between the progressive cytoplasmic expression of a novel small heat shock protein (Hsp16.2) and malignancy in brain tumors. BMC Cancer. 2007;7:233. doi:10.1186/1471-2407-7-233
   PubMed Web of Science ®Google Scholar
• Farkas R, Pozsgai E, Bellyei S, et al. Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer. Anticancer Res. 2011;31(5):1769–1775.
   PubMed Web of Science ®Google Scholar
• Norouzinia M, Zamanian Azodi M, Najafgholizadeh Seyfi D, Kardan A, Naseh A, Akbari Z. Predication of hub target genes of differentially expressed microRNAs contributing to Helicobacter pylori infection in gastric non-cancerous tissue. Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S44–s50.
   PubMedGoogle Scholar
• Boliukh I, Rombel-Bryzek A, Żuk O, Radecka B. The role of heat shock proteins in neoplastic processes and the research on their importance in the diagnosis and treatment of cancer. Contemp Oncol. 2021;25(2):73–79.
   Google Scholar
• Yamada N, Matsushima-Nishiwaki R, Kobayashi K, et al. Cellular Functions of Small Heat Shock Proteins (HSPB) in hepatocellular carcinoma. Curr Mol Med. 2021;21(10):872–887. doi:10.2174/1573405617666210204211252
   PubMed Web of Science ®Google Scholar
• Strik HM, Weller M, Frank B, et al. Heat shock protein expression in human gliomas. Anticancer Res. 2000;20(6b):4457–4462.
   PubMed Web of Science ®Google Scholar
• Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005;436(7051):660–665. doi:10.1038/nature03841
   PubMed Web of Science ®Google Scholar
• Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436(7051):725–730. doi:10.1038/nature03918
   PubMed Web of Science ®Google Scholar
• Yin L, Chang C, Xu C. G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes. Oncotarget. 2017;8(44):76305–76317. doi:10.18632/oncotarget.19351
   PubMedGoogle Scholar
• Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell. 1997;88(3):315–321. doi:10.1016/S0092-8674(00)81870-X
   PubMed Web of Science ®Google Scholar
• Huntington JT, Tang X, Kent LN, Schmidt CR, Leone G. The spectrum of E2F in liver disease–mediated regulation in biology and cancer. J Cell Physiol. 2016;231(7):1438–1449. doi:10.1002/jcp.25242
   PubMed Web of Science ®Google Scholar
• Stanley A, Thompson K, Hynes A, Brakebusch C, Quondamatteo F. NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration. Antioxid Redox Signal. 2014;20(13):2026–2042. doi:10.1089/ars.2013.5713
   PubMed Web of Science ®Google Scholar
• Wong CM, Wei L, Au SL, et al. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget. 2015;6(15):13658–13670. doi:10.18632/oncotarget.3700
   PubMedGoogle Scholar
• Schmidt VA. Watch the GAP: emerging roles for IQ motif-containing GTPase-activating proteins IQGAPs in hepatocellular carcinoma. Int J Hepatol. 2012;2012:958673. doi:10.1155/2012/958673
   PubMedGoogle Scholar
• Brown K, Bhowmick NA. Linking TGF-beta-mediated Cdc25A inhibition and cytoskeletal regulation through RhoA/p160(ROCK) signaling. Cell Cycle. 2004;3(4):408–410. doi:10.4161/cc.3.4.778
   PubMed Web of Science ®Google Scholar
• Fu Y, Li J, Feng MX, et al. Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion. Int J Clin Exp Pathol. 2014;7(5):2123–2132.
   PubMed Web of Science ®Google Scholar
• Ng L, Kwan V, Chow A, et al. Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients. BMC Cancer. 2019;19(1):713. doi:10.1186/s12885-019-5919-3
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Ladu S, Gorden A, et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 2006;130(4):1117–1128. doi:10.1053/j.gastro.2006.01.006
   PubMed Web of Science ®Google Scholar
• Challen C, Guo K, Collier JD, Cavanagh D, Bassendine MF. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol. 1992;14(2–3):342–346. doi:10.1016/0168-8278(92)90181-N
   PubMed Web of Science ®Google Scholar
• Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res. 1989;80(3):196–199. doi:10.1111/j.1349-7006.1989.tb02290.x
   PubMedGoogle Scholar
• Hato T, Goyal L, Greten TF, Duda DG, Zhu AX. Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions. Hepatology. 2014;60(5):1776–1782. doi:10.1002/hep.27246
   PubMed Web of Science ®Google Scholar
• Chen KJ, Lin SZ, Zhou L, et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One. 2011;6(9):e24671. doi:10.1371/journal.pone.0024671
   PubMed Web of Science ®Google Scholar
• Schipilliti FM, Garajová I, Rovesti G, et al. The growing skyline of advanced hepatocellular carcinoma treatment: a review. Pharmaceuticals. 2021;14(1):43. doi:10.3390/ph14010043
   Web of Science ®Google Scholar
• Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99–111. doi:10.1016/j.ccr.2006.06.016
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Lee HL, Jang JW, Lee SW, et al. Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci Rep. 2019;9(1):3260. doi:10.1038/s41598-019-40078-8
   PubMed Web of Science ®Google Scholar
• Ji L, Gu J, Chen L, Miao D. Changes of Th1/Th2 cytokines in patients with primary hepatocellular carcinoma after ultrasound-guided ablation. Int J Clin Exp Pathol. 2017;10(8):8715–8720.
   PubMed Web of Science ®Google Scholar
• Dudek AM, Martin S, Garg AD, Agostinis P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 2013;4:438. doi:10.3389/fimmu.2013.00438
   PubMed Web of Science ®Google Scholar
• Harimoto H, Shimizu M, Nakagawa Y, et al. Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91(9):545–555. doi:10.1038/icb.2013.38
   PubMed Web of Science ®Google Scholar
• Filley AC, Dey M. Dendritic cell based vaccination strategy: an evolving paradigm. J Neurooncol. 2017;133(2):223–235. doi:10.1007/s11060-017-2446-4
   PubMed Web of Science ®Google Scholar
• Constantino J, Gomes C, Falcão A, Neves BM, Cruz MT. Dendritic cell-based immunotherapy: a basic review and recent advances. Immunol Res. 2017;65(4):798–810. doi:10.1007/s12026-017-8931-1
   PubMed Web of Science ®Google Scholar